Medical imaging

SynDevRx Announces Research Collaboration with Maine Medical Center Research Institute to Study the Effects of SDX-7320 In Obesity-Accelerated Multiple Myeloma Models

Tuesday, August 3, 2021 - 12:00pm

The collaboration will study the role of MetAP2 in obesity-accelerated growth and metastatic potential of multiple myeloma a form of cancer that develops in bone marrow.

Key Points: 
  • The collaboration will study the role of MetAP2 in obesity-accelerated growth and metastatic potential of multiple myeloma a form of cancer that develops in bone marrow.
  • "We're excited to test this drug, SDX-7320, in these models of cancers accelerated by obesity," lead investigator Michaela Reagan, PhD, said.
  • "Obesity changes the composition of the blood and bone marrow, making it more conducive for multiple myeloma cells to develop or proliferate.
  • "Maine Medical Center, and Dr. Reagan in particular, have some of the best models for illustrating the effects obesity has on the microenvironment of multiple myeloma," noted SynDevRx Sr. Director of Translational Research, Dr. Peter Cornelius, PhD.

Esaote North America awarded three-year contract agreement with Group Purchasing Organization MAGNET GROUP, offering members access to its full suite of Ultrasound and Dedicated MRI products and services

Tuesday, August 3, 2021 - 12:00pm

The new agreement provides MAGNET GROUP members full access to Esaote North America's comprehensive imaging portfolio and services.

Key Points: 
  • The new agreement provides MAGNET GROUP members full access to Esaote North America's comprehensive imaging portfolio and services.
  • Esaote North America is internationally recognized as a leader in providing superior Ultrasound solutions and Dedicated MRI systems.
  • MAGNET GROUP members can access Esaote North America's suite of products on the MAGNET GROUP website magnetgroup.com under the "Radiology" category.
  • MAGNET GROUP members choose from over 200 no-hassle GPO contracts without volume compliance or bundled services issues and never pay membership dues or fees.

Bio-Techne Announces 2021 Investor Day and Webcast

Tuesday, August 3, 2021 - 12:00pm

MINNEAPOLIS, Aug. 3, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host its 2021 Investor Day on Friday, September 10, 2021, starting at 9:00 a.m. EDT. The meeting will take place at the Lotte New York Palace Hotel, 455 Madison Avenue, New York City.

Key Points: 
  • MINNEAPOLIS, Aug. 3, 2021 /PRNewswire/ --Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host its 2021 Investor Day on Friday, September 10, 2021, starting at 9:00 a.m. EDT.
  • The meeting will take place at the Lotte New York Palace Hotel, 455 Madison Avenue, New York City.
  • The Investor Day will feature presentations from members of Bio-Techne's senior leadership team followed by Q&A.
  • With thousands of products in its portfolio, Bio-Techne generated approximately $739 million in net sales in fiscal 2020 and has approximately 2,600 employees worldwide.

Rigaku Acquires Life Science Imaging Equipment Manufacturer MILabs

Tuesday, August 3, 2021 - 4:30am

Through this acquisition, Rigaku will expand its life sciences modality business globally by combining MILabs' multi-modality businesses, including PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), Optical Imaging, and CT (Computed Tomography) equipment for animals, with Rigaku's original X-ray imaging business for animals.

Key Points: 
  • Through this acquisition, Rigaku will expand its life sciences modality business globally by combining MILabs' multi-modality businesses, including PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), Optical Imaging, and CT (Computed Tomography) equipment for animals, with Rigaku's original X-ray imaging business for animals.
  • Through this acquisition, Rigaku aims to strengthen its pre-clinical imaging business within the life sciences field by incorporating MILabs' radiation imaging and optical imaging technologies, a new initiative for Rigaku, while simultaneously building its existing X-ray imaging business.
  • Rigaku believes that pre-clinical imaging will become increasingly important in the life sciences field.
  • Rigaku will actively enter the life science market and aim to develop this field as one of its core businesses by 2025.

Seasoned Data Science Leader Named President and CEO of M2GEN

Monday, August 2, 2021 - 7:00pm

Mr. Gabriele is a seasoned entrepreneur and data science leader who most recently served as Senior Vice President and Chief Strategy & Data Science Officer, Medical Devices Sector, at Johnson & Johnson.

Key Points: 
  • Mr. Gabriele is a seasoned entrepreneur and data science leader who most recently served as Senior Vice President and Chief Strategy & Data Science Officer, Medical Devices Sector, at Johnson & Johnson.
  • Most recently, as Senior Vice President and Chief Strategy & Data Science Officer for Medical Devices at Johnson & Johnson, he led global strategy development, pricing strategy, data science, data strategy, digital customer experience and business insights.
  • Prior to that, he held senior strategy and data science roles in the Johnson & Johnson Pharmaceutical organization.
  • M2GEN is an oncology-focused health informatics solutions company advancing precision medicine and transforming cancer carethrough clinical and molecular data.

eClinical Solutions' CEO and Co-founder, Raj Indupuri, Honored Among the 2021 PharmaVOICE 100 Most Inspiring People in Life Sciences

Monday, August 2, 2021 - 6:25pm

He is featured in PharmaVOICE magazine's annual July/August issue showcasing inspiring individuals in the global life sciences industry.

Key Points: 
  • He is featured in PharmaVOICE magazine's annual July/August issue showcasing inspiring individuals in the global life sciences industry.
  • The 2021 PharmaVOICE 100 cohort are visionary leaders who have driven the life sciences industry forward throughout the Covid-19 pandemic.
  • "The pandemic proved the need for digital transformation in the life sciences industry, something Raj has been pushing for years," says Taren Grom, editor, PharmaVOICE.
  • To learn more about Raj, eClinical, and the PharmaVOICE 100, visit the July/August 2021 issue: https://www.pharmavoice.com/digital-edition/july-august-2021/#1
    eClinical Solutions helps life sciences organizations around the world accelerate their digital clinical initiatives.

Journal of Mathematical Physics Editor Named Henri Poincaré Prize Laureate

Monday, August 2, 2021 - 3:00pm

WASHINGTON, Aug. 2, 2021 /PRNewswire/ -- The International Association of Mathematical Physics has recognized Jan Philip Solovej, editor-in-chief of the Journal of Mathematical Physics, by AIP Publishing, as a 2021 laureate of the Henri Poincar Prize .

Key Points: 
  • WASHINGTON, Aug. 2, 2021 /PRNewswire/ -- The International Association of Mathematical Physics has recognized Jan Philip Solovej, editor-in-chief of the Journal of Mathematical Physics, by AIP Publishing, as a 2021 laureate of the Henri Poincar Prize .
  • The prize is awarded by the International Association of Mathematical Physics to three to four individuals every three years to recognize and support contributions to the field of mathematical physics.
  • "This is maybe the most prestigious award in the field of mathematical physics.
  • Journal of Mathematical Physics publishes research that connects the application of mathematics to problems in physics, as well as illustrates the development of mathematical methods for such applications and for the formulation of physical theories.

Digital Pathology market set to grow at 11% CAGR to reach $ 1.54 billion by 2030; Companies deploying innovative, data-driven alogithms & business models to grow market

Monday, August 2, 2021 - 2:00pm

Pathology is an area where digitization and automation can bring about significant benefits to patients, physicians, pathologists & labs/hospitals.

Key Points: 
  • Pathology is an area where digitization and automation can bring about significant benefits to patients, physicians, pathologists & labs/hospitals.
  • Faster turnaround time leading to benefits for labs, patients & clinicians
    These benefits, coupled with favourable regulatory environment and reimbursement, is expected to drive the market growth.
  • The Global Digital Pathology Market is estimated to reach $ 1.54 billion by 2030 growing with a CAGR of 11% from 2020-2030.
  • The current Digital Pathology market is dominated by Scanners which are used to digitally scan the samples.

Audeze and SMRT Image announce breakthrough headphones to improve patient comfort, and to support neuroscience research

Monday, August 2, 2021 - 2:00pm

He is also the Co-Founder and Chief Scientist at SMRT Image where he is helping to solve some of the most challenging patient comfort problems with MRI.

Key Points: 
  • He is also the Co-Founder and Chief Scientist at SMRT Image where he is helping to solve some of the most challenging patient comfort problems with MRI.
  • Working with Dr. Cohen and his team at SMRT Image, Audeze helped develop new headphones that alleviate many of the acoustic issues associated with MRI testing.
  • "What we set out to do at SMRT was create a tranquil patient experience within a very hostile environment," says Tylor Garland, CEO of SMRT Image.
  • Lumica is an integrated audio-video solution offering superior patient comfort, two-way communication, and fMRI brain mapping capabilities for both clinical and research applications.

Streamlining Brain Tumor Surgery Care During the Pandemic

Monday, August 2, 2021 - 1:44pm

As U.S. health care eventually emerges from the pandemic, many aspects of surgical care, including how patients are prepared for surgery and where and how they recover will be forever altered.

Key Points: 
  • As U.S. health care eventually emerges from the pandemic, many aspects of surgical care, including how patients are prepared for surgery and where and how they recover will be forever altered.
  • The pandemic's strain on hospital ICUs and other facilities forced the PNI and Saint John's teams to reconsider some basic assumptions about brain tumor care and rapidly implement protocol enhancements that already had been in use on a more limited basis.
  • "Brain tumor surgery by craniotomy or endonasal removal is resource intensive and historically has required multi-day hospital admissions, often including recovery in the ICU," Dr. Kelly added.
  • There were no differences pre-pandemic versus pandemic in tumor removal rates, complications, readmissions or reoperations.